CSIMarket
 


Achillion Pharmaceuticals Inc  (ACHN)
Other Ticker:  
 

Cumulative Achillion Pharmaceuticals Inc's Working Capital Ratio for Trailing Twelve Months Period

ACHN's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

ACHN Working Capital Ratio for Trailing Twelve Months Period

(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
Y / Y Current Liabilities Growth 104.17 % 99.61 % 61.94 % -8.19 % -40.26 %
Y / Y Current Assets Growth -44.89 % -18.64 % -16.29 % -9.4 % -12.41 %
Working Capital Ratio for Trailing Twelve Months Period 15.8 21.23 26.65 31.68 31.55
Total Ranking # 172 # 134 # 102 # 83 # 86
Seq. Current Liabilities Growth 8.54 % 23.09 % 11.41 % 37.16 % 6.12 %
Seq. Current Assets Growth -33.54 % -8.33 % -5.92 % -3.86 % -1.87 %


Working Capital Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2019
On the trailing twelve months basis Due to rise in Current Liabilities in the III. Quarter to $18 millions, average cumulative Working Capital Ratio for Trailing Twelve Months Period decreased to 15.8 below Achillion Pharmaceuticals Inc average Working Capital Ratio for Trailing Twelve Months Period.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 104 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Achillion Pharmaceuticals Inc. While overall ranking remained unchanged compare to previous quarter at no. .

What is Working Capital Ratio?
More about ACHN
Working Capital Ratio ACHN in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 105
Sector # 153
S&P 500 # 338


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
31.92 21.59 11.32
(Sep 30 2016)   (Sep 30 2015)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2019, within Major Pharmaceutical Preparations Industry Working Capital Ratio for Trailing Twelve Months Period
Hookipa Pharma inc   39.10 
Igm Biosciences Inc   38.62 
Gossamer Bio Inc   35.91 
Allakos Inc   29.97 
Nextcure Inc   29.52 
Aurinia Pharmaceuticals Inc   27.90 
Atreca inc   27.38 
Galectin Therapeutics Inc   26.81 
Verrica Pharmaceuticals Inc   25.38 
Bridgebio Pharma Inc   24.65 
Kezar Life Sciences Inc   24.27 
Cassava Sciences Inc  24.10 
Geron Corp  23.47 
Ideaya Biosciences Inc   23.30 
Glycomimetics Inc   21.95 
Applied Therapeutics inc   21.94 
G1 Therapeutics Inc   21.39 
Crinetics Pharmaceuticals Inc   21.36 
Satsuma Pharmaceuticals Inc   21.32 
Synthorx, Inc.  20.70 
Provention Bio Inc   20.35 
Lexaria Bioscience Corp   20.28 
Enanta Pharmaceuticals Inc  20.26 
Aravive Inc   19.97 
Kura Oncology Inc   19.43 
Catalyst Biosciences Inc   18.99 
Ra Pharmaceuticals Inc   18.59 
Reviva Pharmaceuticals Holdings Inc   18.34 
Fulcrum Therapeutics Inc   18.31 
Cryoport inc   18.14 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com